Business Context and Reporting Period
Company: Omeros Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: March 13, 2014
Reporting Period: The filing announces financial results for the three months and the full year ended December 31, 2013.
Key Financial Metrics
The provided text serves as a cover report referencing a press release (Exhibit 99.1) for detailed financial data. The filing text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity.
Note: Specific financial metrics are not present in the source text provided.
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. It only confirms the issuance of a press release containing the results for the periods ended December 31, 2013.
Guidance, Outlook, and Risks
The text contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It strictly references the attached press release for the financial results.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 13, 2014) for actual revenue, net loss, and cash position figures.
- Verify the specific clinical trial progress or product development updates mentioned in the referenced press release, as this is a biopharmaceutical company.
- Confirm the company's cash runway and burn rate as disclosed in the full press release, given the lack of liquidity data in this summary text.